Clinical Trials

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00002583 2020-04-03

Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed

482 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03656393 2018-09-04

RCTACSCNSCLC

48 enrolled

NSCLC

NCT00863512 2017-03-27

Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

34 enrolled 6 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02795884 2016-12-30

Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation

Phase 3 Withdrawn

Lung Neoplasms

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00683514 2016-10-04

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

201 enrolled

NSCLC

NCT00686959 2016-06-28

PROCLAIM

598 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT00345059 2016-01-14

DISTAL-2

84 enrolled

Advanced Non-Small Cell Lung Cancer

NCT02281708 2014-11-03

Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

1,012 enrolled

Lung Neoplasms, Recurrence

NCT00499109 2014-07-09

Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC

275 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00148798 2014-06-25

FLEX

1,861 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003447 2013-12-19

Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

630 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003240 2013-12-18

Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

1,800 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004100 2013-12-18

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003159 2013-12-04

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

600 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00298415 2013-10-25

Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

451 enrolled

NSCLC

NCT00079287 2013-09-17

Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00075699 2013-08-07

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

Other solid neoplasmThoracic

840 enrolled

Mesothelioma, Malignant

NCT00017459 2013-08-02

Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00055887 2013-05-10

Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 3 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00002823 2013-03-28

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

3,300 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00005838 2013-01-23

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

756 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT00042315 2012-05-23

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

490 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00737867 2011-04-04

Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

444 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00193362 2010-07-28

Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer

200 enrolled

Lung Neoplasms

NCT00441740 2008-10-31

Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer

419 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00441922 2008-10-29

Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)

166 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00148395 2008-04-22

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

280 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00148291 2006-01-06

Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer

180 enrolled

Lung Neoplasms

NCT00265694 2005-12-15

Random Trial for Elderly Patients With NSCLC